Therapeutic implications of exosomes in the treatment of radiation injury

Shijie Dai , Yuzhong Wen , Peng Luo , Le Ma , Yunsheng Liu , Junhua Ai , Chunmeng Shi

Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) : tkab043

PDF (994KB)
Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) :tkab043 DOI: 10.1093/burnst/tkab043
Review
research-article
Therapeutic implications of exosomes in the treatment of radiation injury
Author information +
History +
PDF (994KB)

Abstract

Radiotherapy is one of the main cancer treatments, but it may damage normal tissue and cause various side effects. At present, radioprotective agents used in clinics have side effects such as nausea, vomiting, diarrhea and hypotension, which limit their clinical application. It has been found that exosomes play an indispensable role in radiation injury. Exosomes are lipid bilayer vesicles that carry various bioactive substances, such as proteins, lipids and microRNA (miRNA), that play a key role in cell-to-cell communication and affect tissue injury and repair. In addition, studies have shown that radiation can increase the uptake of exosomes in cells and affect the composition and secretion of exosomes. Here, we review the existing studies and discuss the effects of radiation on exosomes and the role of exosomes in radiation injury, aiming to provide new insights for the treatment of radiation injury.

Keywords

Exosome / Radiation injury / Treatment

Cite this article

Download citation ▾
Shijie Dai, Yuzhong Wen, Peng Luo, Le Ma, Yunsheng Liu, Junhua Ai, Chunmeng Shi. Therapeutic implications of exosomes in the treatment of radiation injury. Burns & Trauma, 2022, 10 (1) : tkab043 DOI:10.1093/burnst/tkab043

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Flynn DF, Goans RE. Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg Clin North Am. 2006; 86: 601-36.

[2]

Li S, Shao L, Xu T, Jiang X, Yang G, Dong L. An indispensable tool: exosomes play a role in therapy for radiation damage. Biomed Pharmacother. 2021; 137: 111401.

[3]

Tuncay Cagatay S, Mayah A, Mancuso M, Giardullo P, Pazza glia S, Saran A, et al. Phenotypic and functional characteristics of exosomes derived from irradiated mouse organs and their role in the mechanisms driving non-targeted effects. Int J Mol Sci. 2020; 21: 8389.

[4]

Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol. 2010; 20: 201-7.

[5]

Pu X, Ma S, Gao Y, Xu T, Chang P, Dong L. Mesenchymal stem cell-derived exosomes: biological function and their therapeutic potential in radiation damage. Cell. 2020; 10: 42.

[6]

Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012; 327: 48-60.

[7]

Green DE, Adler BJ, Chan ME, Rubin CT. Devastation of adult stem cell pools by irradiation precedes collapse of trabecular bone quality and quantity. J Bone Miner Res. 2012; 27: 749-59.

[8]

Hou J, Han ZP, Jing YY, Yang X, Zhang SS, Sun K, et al. Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells. Cell Death Dis. 2013; 4: e844.

[9]

Lowe DJ, Herzog M, Mosler T, Cohen H, Felton S, Beli P, et al. Chronic irradiation of human cells reduces histone levels and deregulates gene expression. Sci Rep. 2020; 10: 2200.

[10]

Rajan Radha R, Chandrasekharan G. Pulmonary injury associated with radiation therapy-assessment, complications and therapeutic targets. Biomed Pharmacother. 2017; 89: 1092-104.

[11]

Arora R, Gupta D, Chawla R, Sagar R, Sharma A, Kumar R, et al. Radioprotection by plant products: present status and future prospects. Phytother Res. 2005; 19: 1-22.

[12]

Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367: eaau6977.

[13]

Phinney DG, Pittenger MF. Concise review: MSC-derived exo somes for cell-free therapy. Stem Cells. 2017; 35: 2103.

[14]

Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014; 14: 195-208.

[15]

Miksa M, Wu R, Dong W, Komura H, Amin D, Ji Y, et al. Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII. J Immunol. 2009; 183: 5983-90.

[16]

Munson P, Shukla A. Exosomes: potential in cancer diagnosis and therapy. Medicine. 2015; 2: 310-27.

[17]

Feng Y, Huang W, Meng W, Jegga AG, Wang Y, Cai W, et al. Heat shock improves Sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway. Stem Cells. 2014; 32: 462-72.

[18]

Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, Krishnamurthy P, et al. Embryonic stem cell-derived exo somes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015; 117: 52-64.

[19]

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29: 341-5.

[20]

Tan C, Lai R, Wong W, Dan Y, Lim S-K, Ho H. Mesenchy mal stem cell-derived exosomes promote hepatic regenera tion in drug-induced liver injury models. Stem Cell Res Ther. 2014; 5: 76.

[21]

Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extra cellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016; 106: 148-56.

[22]

Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008; 16: 782-90.

[23]

Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654-9.

[24]

Lu M, Zhao X, Xing H, Xun Z, Zhu S, Lang L, et al. Com parison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int J Pharm. 2018; 550: 100-13.

[25]

Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012; 3: 359.

[26]

Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weiss man IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428: 668-73.

[27]

Jeong JO, Han JW, Kim JM, Cho HJ, Park C, Lee N, et al. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res. 2011; 108: 1340-7.

[28]

He C, Zheng S, Luo Y, Wang B. Exosome Theranostics: biology and translational medicine. Theranostics. 2018; 8: 237-55.

[29]

Hazawa M, Tomiyama K, Saotome-Nakamura A, Obara C, Yasuda T, Gotoh T, et al. Radiation increases the cellular uptake of exosomes through CD29/CD81 complex formation. Biochem Biophys Res Commun. 2014; 446: 1165-71.

[30]

Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, et al. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis. 2013; 4: e544.

[31]

Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. V esicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987; 262: 9412-20.

[32]

Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011; 9: 9.

[33]

Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012; 10: 5.

[34]

Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012; 1820: 940-8.

[35]

Pan BT, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 1985; 101: 942-8.

[36]

van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19: 213-28.

[37]

Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015; 8: 83.

[38]

Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Hard ing CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996; 183: 1161-72.

[39]

Yuana Y, Koning RI, Kuil ME, Rensen PC, Koster AJ, Bertina RM, et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma. J Extracell Vesicles. 2013; 2.

[40]

Höög JL, Lötvall J. Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy. J Extracell Vesicles. 2015; 4: 28680.

[41]

Zabeo D, Cvjetkovic A, Lässer C, Schorb M, Lötvall J, Höög JL. Exosomes purified from a single cell type have diverse morphology. J Extracell Vesicles. 2017; 6: 1329476.

[42]

Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position state ment of the International Society for Extracellular Vesicles and Update of the MISEV2014 guidelines. J Extracell Vesicles. 2018; 7: 1535750.

[43]

Kanemoto S, Nitani R, Murakami T, Kaneko M, Asada R, Matsuhisa K, et al. Multivesicular body formation enhance ment and exosome release during endoplasmic reticulum stress. Biochem Biophys Res Commun. 2016; 480: 166-72.

[44]

Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006; 3: 3.22.

[45]

Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl). 2013; 91: 431-7.

[46]

Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010; 12: 19-30 sup pp 1-13.

[47]

Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2016; 22: 1502.

[48]

Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specifici ties of secretion and uptake of exosomes and other extracel lular vesicles for cell-to-cell communication. Nat Cell Biol. 2019; 21: 9-17.

[49]

Ferguson SW, Nguyen J. Exosomes as therapeutics: the impli cations of molecular composition and exosomal heterogeneity. J Control Release. 2016; 228: 179-90.

[50]

Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J Neural Transm (Vienna). 2010; 117: 1-4.

[51]

Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: a web-based compendium of Exosomal cargo. J Mol Biol. 2016; 428: 688-92.

[52]

Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018; 46: D106-12.

[53]

Liu T, Zhang Q, Zhang J, Li C, Miao YR, Lei Q, et al. EVmiRNA: a database of miRNA profiling in extracellular vesicles. Nucleic Acids Res. 2019; 47: D89-93.

[54]

Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Möbius W, Hoernschemeyer J, et al. Proteomic and biochemi cal analyses of human B cell-derived exosomes. Potential impli cations for their function and multivesicular body formation. J Biol Chem. 2003; 278: 10963-72.

[55]

Choi DS, Kim DK, Kim YK, Gho YS. Proteomics of extracel lular vesicles: exosomes and ectosomes. Mass Spectrom Rev. 2015; 34: 474-90.

[56]

Li W, Li C, Zhou T, Liu X, Liu X, Li X, et al. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017; 16: 145.

[57]

Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012; 40: 10937-49.

[58]

Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319: 1244-7.

[59]

Subra C, Laulagnier K, Perret B, Record M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie. 2007; 89: 205-12.

[60]

Cong W, Niu C, Lv L, Ni M, Ruan D, Chi L, et al. Metallothionein prevents age-associated cardiomyopathy via inhibiting NF-κB pathway activation and associated Nitra tive damage to 2-OGD. Antioxid Redox Signal. 2016; 25: 936-52.

[61]

Lu FB, Chen DZ, Chen L, Hu ED, Wu JL, Li H, et al. Attenu ation of experimental autoimmune hepatitis in mice with bone mesenchymal stem cell-derived exosomes carrying MicroRNA-223-3p. Mol Cells. 2019; 42: 906-18.

[62]

Du W, Zhang K, Zhang S, Wang R, Nie Y, Tao H, et al. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer. Biomaterials. 2017; 133: 70-81.

[63]

Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z, et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Bio mater. 2020; 103: 196-212.

[64]

Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9: 19.

[65]

Salehi M, Sharifi M. Exosomal miRNAs as novel cancer biomarkers: challenges and opportunities. J Cell Physiol. 2018; 233: 6370-80.

[66]

Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, et al. Evalu ation of tumor-derived Exosomal miRNA as potential diag nostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 2017; 23: 5311-9.

[67]

Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, et al. The evolving landscape of exosomes in neurodegenerative diseases: exosomes characteristics and a promising role in early diagnosis. Int J Mol Sci. 2021; 22: 440.

[68]

Zamani P, Fereydouni N, Butler AE, Navashenaq JG, Sahe bk ar A. The therapeutic and diagnostic role of exosomes in cardiovascular diseases. Trends Cardiovasc Med. 2019; 29: 313-23.

[69]

Sahoo S, Adamiak M, Mathiyalagan P, Kenneweg F, Kafert-Kasting S, Thum T. Therapeutic and diagnostic translation of extracellular vesicles in cardiovascular diseases: roadmap to the clinic. Circulation. 2021; 143: 1426-49.

[70]

Masyuk AI, Masyuk TV, Larusso NF. Exosomes in the patho genesis, diagnostics and therapeutics of liver diseases. J Hepa tol. 2013; 59: 621-5.

[71]

Zhang W, Zhou X, Zhang H, Yao Q, Liu Y, Dong Z. Extracel lular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016; 311: F844-51.

[72]

Alipoor SD, Mortaz E, Garssen J, Movassaghi M, Mirsaeidi M, Adcock IM. Exosomes and Exosomal miRNA in respiratory diseases. Mediators Inflamm. 2016;2016:5628404.

[73]

Zhao M, Juanjuan L, Weijia F, Jing X, Qiuhua H, Hua Z, et al. Expression levels of MicroRNA-125b in serum exosomes of patients with asthma of different severity and its diagnostic significance. Curr Drug Metab. 2019; 20: 781-4.

[74]

He C, Li L, Wang L, Meng W, Hao Y, Zhu G. Exosome-mediated cellular crosstalk within the tumor microenvironment upon irradiation. Cancer Biol Med. 2021; 18: 21-33.

[75]

Luo A, Zhou X, Shi X, Zhao Y, Men Y, Chang X, et al. Exosome-derived miR-339-5p mediates radiosensitivity by tar geting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 2019; 38: 4990-5006.

[76]

Kulkarni S, Koller A, Mani KM, Wen R, Alfieri A, Saha S, et al. Identifying urinary and serum exosome biomarkers for radiation exposure using a data dependent acquisition and SWATH-MS combined workflow. Int J Radiat Oncol Biol Phys. 2016; 96: 566-77.

[77]

Arscott WT, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, et al. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol. 2013; 6: 638-IN6.

[78]

Lehmann BD, Paine MS, Brooks AM, McCubrey JA, Renegar RH, Wang R, et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 2008; 68: 7864-71.

[79]

Jelonek K, Widlak P, Pietrowska M. The influence of ionizing radiation on exosome composition, secretion and intercellular communication. Protein Pept Lett. 2016; 23: 656-63.

[80]

Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008; 15: 1723-33.

[81]

Jella KK, Rani S, O’Driscoll L, McClean B, Byrne HJ, Lyng FM. Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells. Radiat Res. 2014; 181: 138-45.

[82]

Al-Mayah A, Bright S, Chapman K, Irons S, Luo P, Carter D, et al. The non-targeted effects of radiation are perpetuated by exosomes. Mutat Res. 2015; 772: 38-45.

[83]

Bagheri HS, Mousavi M, Rezabakhsh A, Rezaie J, Rasta SH, Nourazarian A, et al. Low-level laser irradiation at a high power intensity increased human endothelial cell exosome secretion via Wnt signaling. Lasers Med Sci. 2018; 33: 1131-45.

[84]

Agarwal K, Saji M, Lazaroff SM, Palmer AF, Ringel MD, Paulaitis ME. Analysis of exosome release as a cellular response to MAPK pathway inhibition. Langmuir. 2015; 31: 5440-8.

[85]

Jelonek K, Wojakowska A, Marczak L, Muer A, Tinhofer-Keilholz I, Lysek-Gladysinska M, et al. Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma. Acta Biochim Pol. 2015; 62: 265-72.

[86]

Shen Z, Sun J, Shao J, Xu J. Ultraviolet B irradiation enhances the secretion of exosomes by human primary melanocytes and changes their exosomal miRNA profile. PLoS One. 2020; 15: e0237023.

[87]

Schaue D, McBride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015; 12: 527-40.

[88]

Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, Dugave C, et al. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. Gastroenterology. 2007; 132: 1866-76.

[89]

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015; 527: 329-35.

[90]

Prise KM, Saran A. Concise review: stem cell effects in radiation risk. Stem Cells. 2011; 29: 1315-21.

[91]

Sha J, Arbesman J, Harter ML. Premature senescence in human melanocytes after exposure to solar UVR: An exosome and UV-miRNA connection. Pigment Cell Melanoma Res. 2020; 33: 671-84.

[92]

Marcu LG. Altered fractionation in radiotherapy: from radio biological rationale to therapeutic gain. Cancer Treat Rev. 2010; 36: 606-14.

[93]

Ryan JL. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol. 2012; 132: 985-93.

[94]

Horton JA, Hudak KE, Chung EJ, White AO, Scroggins BT, Burkeen JF, et al. Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflamma tion. Stem Cells. 2013; 31: 2231-41.

[95]

Bray FN, Simmons BJ, Wolfson AH, Nouri K. Acute and chronic cutaneous reactions to ionizing radiation therapy. Der matol Ther (Heidelb). 2016; 6: 185-206.

[96]

Spalek M. Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol. 2016; 9: 473-82.

[97]

Suárez B, López-Abente G, Martínez C, Navarro C, Tormo MJ, Rosso S, et al. Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study. BMC Public Health. 2007; 7: 180.

[98]

Karagas MR, Nelson HH, Zens MS, Linet M, Stukel TA, Spencer S, et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential mod ification of risk by sun exposure. Epidemiology. 2007; 18: 776-84.

[99]

Martin MT, Vulin A, Hendry JH. Human epidermal stem cells: role in adverse skin reactions and carcinogenesis from radiation. Mutat Res. 2016; 770: 349-68.

[100]

McDougall S, Dallon J, Sherratt J, Maini P.Fibroblast migra tion and collagen deposition during dermal wound healing: mathematical modelling and clinical implications. Philos Trans A Math Phys Eng Sci. 2006; 364: 1385-405.

[101]

Bae YU, Son Y, Kim CH, Kim KS, Hyun SH, Woo HG, et al. Embryonic stem cell-derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF-B receptor 2 pathway. J Gerontol A Biol Sci Med Sci. 2019; 74: 1359-67.

[102]

Galvez-Martín P, Martin JM, Ruiz AM, Clares B. Encapsu lation in cell therapy: methodologies, materials, and clinical applications. Curr Pharm Biotechnol. 2017; 18: 365-77.

[103]

Maguire G.Stem cell therapy without the cells. Commun Integr Biol. 2013; 6: e26631.

[104]

Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O’Kane CM, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017; 196: 1275-86.

[105]

Gao S, Chen T, Hao Y, Zhang F, Tang X, Wang D, et al. Exoso mal miR-135a derived from human amnion mesenchymal stem cells promotes cutaneous wound healing in rats and fibroblast migration by directly inhibiting LATS2 expression. Stem Cell Res Ther. 2020; 11: 56.

[106]

Tao SC, Guo SC, Li M, Ke QF, Guo YP, Zhang CQ. Chi tosan wound dressings incorporating exosomes derived from MicroRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model. Stem Cells Transl Med. 2017; 6: 736-47.

[107]

Wang T, Jian Z, Baskys A, Yang J, Li J, Guo H, et al. MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. Biomaterials. 2020; 257: 120264.

[108]

Liu H, Liang Z, Wang F, Zhou C, Zheng X, Hu T, et al. Exo somes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight. 2019; 4: e131273.

[109]

Domenis R, Cifù A, Quaglia S, Pistis C, Moretti M, Vicario A, et al. Pro inflammatory stimuli enhance the immunosup pressive functions of adipose mesenchymal stem cells-derived exosomes. Sci Rep. 2018; 8: 13325.

[110]

Vergadi E, Vaporidi K, Theodorakis EE, Doxaki C, Lagoudaki E, Ieronymaki E, et al. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J Immunol. 2014; 192: 394-406.

[111]

Jiang P, Liu R, Zheng Y, Liu X, Chang L, Xiong S, et al. MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages. Exp Cell Res. 2012; 318: 1175-84.

[112]

Jiang X, Jiang X, Qu C, Chang P, Zhang C, Qu Y, et al. Intravenous delivery of adipose-derived mesenchymal stromal cells attenuates acute radiation-induced lung injury in rats. Cytotherapy. 2015; 17: 560-70.

[113]

Zuo R, Liu M, Wang Y, Li J, Wang W, Wu J, et al. BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signaling. Stem Cell Res Ther. 2019; 10: 30.

[114]

Gan F, Wang R, Lyu P, Li Y, Fu R, Du Y, et al. Plasma-derived exosomes boost the healing of irradiated wound by regulat ing cell proliferation and Ferroptosis. J Biomed Nanotechnol. 2021; 17: 100-14.

[115]

Hu S, Li Z, Cores J, Huang K, Su T, Dinh PU, et al. Needle-free injection of exosomes derived from human dermal fibroblast spheroids ameliorates skin Photoaging. ACS Nano. 2019; 13: 11273-82.

[116]

Liang JX, Liao X, Li SH, Jiang X, Li ZH, Wu YD, et al. Antiaging properties of exosomes from adipose-derived mes enchymal stem cells in Photoaged rat skin. Biomed Res Int. 2020; 2020: 6406395.

[117]

Morgan WF, Sowa MB. Non-targeted effects induced by ion izing radiation: mechanisms and potential impact on radiation induced health effects. Cancer Lett. 2015; 356: 17-21.

[118]

Tan W, Zhang Y, Li M, Zhu X, Yang X, Wang J, et al. miR-27a-containing exosomes secreted by irradiated skin keratinocytes delayed the migration of Unirradiated skin fibroblasts. Int J Biol Sci. 2019; 15: 2240-55.

[119]

Ni N, Ma W, Tao Y, Liu J, Hua H, Cheng J, et al. Exosomal MiR-769-5p exacerbates ultraviolet-induced bystander effect by targeting TGFBR1. Front Physiol. 2020; 11: 603081.

[120]

Trott KR, Herrmann T, Kasper M. Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys. 2004; 58: 463-9.

[121]

Nagarajan D, Melo T, Deng Z, Almeida C, Zhao W. ERK/GSK3β/snail signaling mediates radiation-induced alveo lar epithelial-to-mesenchymal transition. Free Radic Biol Med. 2012; 52: 983-92.

[122]

Giuranno L, Ient J, De Ruysscher D, Vooijs MA. Radiation-induced lung injury (RILI). Front Oncol. 2019; 9: 877.

[123]

Ding NH, Li JJ, Sun LQ. Molecular mechanisms and treat ment of radiation-induced lung fibrosis. Curr Drug Targets. 2013; 14: 1347-56.

[124]

Xia C, Chang P, Zhang Y, Shi W, Liu B, Ding L, et al. Thera peutic effects of bone marrow-derived mesenchymal stem cells on radiation-induced lung injury. Oncol Rep. 2016; 35: 731-8.

[125]

Xu S, Liu C, Ji HL. Concise review: therapeutic potential of the mesenchymal stem cell derived Secretome and extracel lular vesicles for radiation-induced lung injury: progress and hypotheses. Stem Cells Transl Med. 2019; 8: 344-54.

[126]

Epperly MW, Guo H, Gretton JE, Greenberger JS. Bone mar row origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003; 29: 213-24.

[127]

Rubin P, Johnston CJ, Williams JP, McDonald S, Finkel stein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995; 33: 99-109.

[128]

Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3: 349-63.

[129]

Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006; 3: 383-8.

[130]

Meziani L, Mondini M, Petit B, Boissonnas A, Thomas de Montpreville V, Mercier O, et al. CSF1R inhibition pre vents radiation pulmonary fibrosis by depletion of interstitial macrophages. Eur Respir J. 2018; 51: 1702120.

[131]

Abernathy LM, Fountain MD, Rothstein SE, David JM, Yunker CK, Rakowski J, et al. Soy Isoflavones promote radioprotec tion of normal lung tissue by inhibition of radiation-induced activation of macrophages and neutrophils. J Thorac Oncol. 2015; 10: 1703-12.

[132]

Huang Y, Zhang W, Yu F, Gao F. The cellular and molecular mechanism of radiation-induced lung injury. Med Sci Monit. 2017; 23: 3446-50.

[133]

Park HR, Jo SK, Jung U. Ionizing radiation promotes epithelial-to-mesenchymal transition in lung epithelial cells by TGF-β-producing M2 macrophages. In Vivo. 2019; 33: 1773-84.

[134]

Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex ’wound’. Radiother Oncol. 2002; 63: 129-45.

[135]

Wynn TA.Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011; 208: 1339-50.

[136]

Horie S, Laffey JG. Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome. F1000Res. 2016; 5: F1000 Faculty Rev-1532.

[137]

Bury MI, Fuller NJ, Wethekam L, Sharma AK. Bone marrow derived cells facilitate urinary bladder regeneration by atten uating tissue inflammatory responses. Cent European J Urol. 2015; 68: 115-20.

[138]

Xue J, Li X, Lu Y, Gan L, Zhou L, Wang Y, et al. Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol Ther. 2013; 21: 456-65.

[139]

Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflam matory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A. 2007; 104: 11002-7.

[140]

Zhang B, Yin Y, Lai RC, Tan SS, Choo AB, Lim SK. Mesenchy mal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014; 23: 1233-44.

[141]

Xiong S, Pan X, Xu L, Yang Z, Guo R, Gu Y, et al. Regulatory T cells promote β-catenin-mediated epithelium-to-mesenchyme transition during radiation-induced pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 2015; 93: 425-35.

[142]

Blazquez R, Sanchez-Margallo FM, de la Rosa O, Dalemans W, Alvarez V, Tarazona R, et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol. 2014; 4: 556.

[143]

Moon HG, Cao Y, Yang J, Lee JH, Choi HS, Jin Y. Lung epithe lial cell-derived extracellular vesicles activate macrophage-mediated inflammatory responses via ROCK1 pathway. Cell Death Dis. 2015; 6: e2016.

[144]

Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernås M, et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One. 2010; 5: e15353.

[145]

Tomasik B, Chałubińska-Fendler J, Chowdhury D, Fendler W. Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy. Transl Res. 2018; 201: 71-83.

[146]

Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, Jin HO, et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol. 2009; 35: 81-6.

[147]

Liu M, Liu L, Bai M, Zhang L, Ma F, Yang X, et al. Hypoxia-induced activation of twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis. Biochem Biophys Res Commun. 2018; 495: 2324-30.

[148]

Ti D, Hao H, Fu X, Han W. Mesenchymal stem cells-derived exosomal microRNAs contribute to wound inflammation. Sci China Life Sci. 2016; 59: 1305-12.

[149]

Saba R, Sorensen DL, Booth SA. MicroRNA-146a: a domi nant, negative regulator of the innate immune response. Front Immunol. 2014; 5: 578.

[150]

Li X, Liu L, Yang J, Yu Y, Chai J, Wang L, et al. Exo some derived from human umbilical cord mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive inflammation. EBioMedicine. 2016; 8: 72-82.

[151]

Etzrodt M, Cortez-Retamozo V, Newton A, Zhao J, Ng A, Wildgruber M, et al. Regulation of monocyte functional het erogeneity by miR-146a and Relb. Cell Rep. 2012; 1: 317-24.

[152]

Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015; 13: 308.

[153]

Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi H, et al. Umbilical cord-derived mesenchymal stem cell-derived Exo somal MicroRNAs suppress Myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 path way during wound healing. Stem Cells Transl Med. 2016; 5: 1425-39.

[154]

Wang B, Yao K, Huuskes BM, Shen HH, Zhuang J, Godson C, et al. Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther. 2016; 24: 1290-301.

[155]

Qian X, Xu C, Fang S, Zhao P, Wang Y, Liu H, et al. Exosomal MicroRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection. Stem Cells Transl Med. 2016; 5: 1190-203.

[156]

Yi X, Wei X, Lv H, An Y, Li L, Lu P, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019; 383: 111454.

[157]

Williams JP, Brown SL, Georges GE, Hauer-Jensen M, Hill RP, Huser AK, et al. Animal models for medical countermeasures to radiation exposure. Radiat Res. 2010; 173: 557-78.

[158]

Green DE, Rubin CT. Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors. Bone. 2014; 63: 87-94.

[159]

Donaubauer AJ, Deloch L, Becker I, Fietkau R, Frey B, Gaipl US. The influence of radiation on bone and bone cells-differential effects on osteoclasts and osteoblasts. Int J Mol Sci. 2020; 21: 6377.

[160]

Iaquinta MR, Mazzoni E, Bononi I, Rotondo JC, Mazziotta C, Montesi M, et al. Adult stem cells for bone regeneration and repair. Front Cell Dev Biol. 2019; 7: 268.

[161]

Nanduri LSY, Duddempudi PK, Yang WL, Tamarat R, Guha C. Extracellular vesicles for the treatment of radiation injuries. Front Pharmacol. 2021; 12: 662437.

[162]

Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, et al. Osteoimmunology: the con ceptual framework unifying the immune and skeletal systems. Physiol Rev. 2017; 97: 1295-349.

[163]

Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25: 2739-49.

[164]

Szymczyk KH, Shapiro IM, Adams CS. Ionizing radiation sensitizes bone cells to apoptosis. Bone. 2004; 34: 148-56.

[165]

Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y. Differen tiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit. 2016; 22: 226-33.

[166]

Deng Y, Wu S, Zhou H, Bi X, Wang Y, Hu Y, et al. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. Stem Cells Dev. 2013; 22: 2278-86.

[167]

Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, et al. Dex amethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation. Cell Death Dis. 2013; 4: e832.

[168]

Wang Y, Zhu G, Wang J, Chen J. Irradiation alters the differen tiation potential of bone marrow mesenchymal stem cells. Mol Med Rep. 2016; 13: 213-23.

[169]

Zhang X, Xiang L, Ran Q, Liu Y, Xiang Y, Xiao Y, et al. Crif1 promotes adipogenic differentiation of bone marrow mesenchymal stem cells after irradiation by modulating the PKA/CREB signaling pathway. Stem Cells. 2015; 33: 1915-26.

[170]

Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and applica tion in osteoporosis treatment. Int J Mol Sci. 2018; 19: 360.

[171]

Mianehsaz E, Mirzaei HR, Mahjoubin-Tehran M, Rezaee A, Sahebnasagh R, Pourhanifeh MH, et al. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 2019; 10: 340.

[172]

Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noël D. Mesenchy mal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017; 7: 16214.

[173]

Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015; 40: 82-8.

[174]

Zhang J, Liu X, Li H, Chen C, Hu B, Niu X, et al. Exosomes/tri calcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016; 7: 136.

[175]

Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mes enchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci. 2016; 12: 836-49.

[176]

Ekström K, Omar O, Granéli C, Wang X, Vazirisani F, Thomsen P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PLoS One. 2013; 8: e75227.

[177]

Xu JF, Yang GH, Pan XH, Zhang SJ, Zhao C, Qiu BS, et al. Altered microRNA expression profile in exosomes dur ing osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. PLoS One. 2014; 9: e114627.

[178]

Wei J, Li H, Wang S, Li T, Fan J, Liang X, et al. Let-7 enhances osteogenesis and bone formation while repressing adipogen esis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev. 2014; 23: 1452-63.

[179]

Zhang WB, Zhong WJ, Wang L. A signal-amplification circuit between miR-218 and Wnt/β-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone. 2014; 58: 59-66.

[180]

Bhushan R, Grünhagen J, Becker J, Robinson PN, Ott CE, Knaus P. miR-181a promotes osteoblastic differentia tion through repression of TGF-β signaling molecules. Int J Biochem Cell Biol. 2013; 45: 696-705.

[181]

Du Y, Tang H, Gu X, Shi Y, Gong P, Yao Y. Radiation can regulate the expression of miRNAs associated with osteogene sis and oxidation in exosomes from peripheral blood plasma. Oxid Med Cell Longev. 2021; 2021: 6646323.

[182]

Behera J, Tyagi N. Exosomes: mediators of bone diseases, protection, and therapeutics potential. Onco Targets Ther. 2018; 5: 181-95.

[183]

Zhao L, Jiang S, Hantash BM. Transforming growth factor beta1 induces osteogenic differentiation of murine bone mar row stromal cells. Tissue Eng Part A. 2010; 16: 725-33.

[184]

Cui Y, Luan J, Li H, Zhou X, Han J. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differ entiation by alteration of microRNA expression. FEBS Lett. 2016; 590: 185-92.

[185]

Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J, et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res. 2011; 26: 1953-63.

[186]

You L, Gu W, Chen L, Pan L, Chen J, Peng Y. MiR-378 over expression attenuates high glucose-suppressed osteogenic dif ferentiation through targeting CASP3 and activating PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 2014; 7: 249-61.

[187]

Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI workshop, December 3-4, 2003. Radiat Res. 2004; 162: 711-28.

[188]

Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncolo gist. 2007; 12: 738-47.

[189]

Raviraj J, Bokkasam VK, Kumar VS, Reddy US, Suman V. Radiosensitizers, radioprotectors, and radiation mitigators. Indian J Dent Res. 2014; 25: 83-90.

[190]

Singh VK, Seed TM. The efficacy and safety of amifostine for the acute radiation syndrome. Expert Opin Drug Saf. 2019; 18: 1077-90.

[191]

King M, Joseph S, Albert A, Thomas TV, Nittala MR, Woods WC, et al. Use of Amifostine for Cytoprotection during radia tion therapy: a review. Oncology. 2020; 98: 61-80.

[192]

Bhanja P, Norris A, Gupta-Saraf P, Hoover A, Saha S. BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury. Stem Cell Res Ther. 2018; 9: 26.

[193]

Brown M. What causes the radiation gastrointestinal syn drome?: overview. Int J Radiat Oncol Biol Phys. 2008; 70: 799-800.

[194]

Lu X, Nurmemet D, Bolduc DL, Elliott TB, Kiang JG. Radioprotective effects of oral 17-dimethylaminoethylamino-17-demethoxygeldanamycin in mice: bone marrow and small intestine. Cell Biosci. 2013; 3: 36.

[195]

Saha S, Aranda E, Hayakawa Y, Bhanja P, Atay S, Brodin NP, et al. Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury. Nat Commun. 2016; 7: 13096.

[196]

Accarie A, et al. Extracellular vesicles derived from mesenchy mal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome. Stem Cell Res Ther. 2020; 11: 371.

[197]

Rocchi C, Emmerson E. Mouth-watering results: clinical need, current approaches, and future directions for salivary gland regeneration. Trends Mol Med. 2020; 26: 649-69.

[198]

Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow dur ing high dose radiotherapy. Radiother Oncol. 2001; 2001: 271-4.

[199]

Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stok man MA, Kok T, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One. 2008; 3: e2063.

[200]

Sumita Y, Liu Y, Khalili S, Maria OM, Xia D, Key S, et al. Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation. Int J Biochem Cell Biol. 2011; 43: 80-7.

[201]

Lim JY, Ra JC, Shin IS, Jang YH, An HY, Choi JS, et al. Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PLoS One. 2013; 8: e71167.

[202]

Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014; 28: 970-3.

[203]

Marbán E. The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol. 2018; 71: 193-200.

[204]

Xian P, Hei Y, Wang R, Wang T, Yang J, Li J, et al. Mesenchy mal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9: 5956-75.

[205]

Zhou X, Li Z, Qi M, Zhao P, Duan Y, Yang G, et al. Brown adi pose tissue-derived exosomes mitigate the metabolic syndrome in high fat diet mice. Theranostics. 2020; 10: 8197-210.

[206]

Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018; 150: 137-49.

[207]

Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A, et al. Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous Leukemia cell growth. Theranostics. 2017; 7: 1333-45.

[208]

Kojima R, Bojar D, Rizzi G, Hamri GC, El-Baba MD, Sax ena P, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat Commun. 2018; 9: 1305.

[209]

Abramowicz A, Łabaj W, Mika J, Szołtysek K, Ślęzak-Prochazka I, Mielańczyk Ł, et al. MicroRNA profile of exo somes and parental cells is differently affected by ionizing radiation. Radiat Res. 2020; 194: 133-42.

[210]

Jeyaram A, Lamichhane TN, Wang S, Zou L, Dahal E, Kron stadt SM, et al. Enhanced loading of functional miRNA cargo via pH gradient modification of extracellular vesicles. Mol Ther. 2020; 28: 975-85.

PDF (994KB)

19

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉